Crossject
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster he… Read more
Market Cap & Net Worth: Crossject (ALCJ)
Crossject (PA:ALCJ) has a market capitalization of $112.62 Million (€109.72 Million) as of March 18, 2026. Listed on the PA stock exchange, this France-based company holds position #18010 globally and #111 in its home market, demonstrating a 4.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Crossject's stock price €2.09 by its total outstanding shares 52495622 (52.50 Million).
Crossject Market Cap History: 2015 to 2026
Crossject's market capitalization history from 2015 to 2026. Data shows change from $527.48 Million to $112.62 Million (-5.71% CAGR).
Index Memberships
Crossject is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC PME
CAPME
|
$8.81 Billion | 1.20% | #9 of 34 |
Weight: Crossject's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Crossject Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Crossject's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
29.07x
Crossject's market cap is 29.07 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $527.48 Million | $1.59 Million | -$5.69 Million | 332.58x | N/A |
| 2016 | $230.55 Million | $1.42 Million | -$6.66 Million | 162.05x | N/A |
| 2017 | $238.12 Million | $3.23 Million | -$7.61 Million | 73.62x | N/A |
| 2018 | $64.05 Million | $2.44 Million | -$10.71 Million | 26.21x | N/A |
| 2019 | $122.15 Million | $500.00K | -$7.17 Million | 244.31x | N/A |
| 2020 | $162.78 Million | $4.84 Million | -$9.84 Million | 33.60x | N/A |
| 2021 | $151.36 Million | $912.00K | -$10.81 Million | 165.97x | N/A |
| 2022 | $176.01 Million | $954.00K | -$11.16 Million | 184.49x | N/A |
| 2023 | $265.47 Million | $145.00K | -$8.64 Million | 1830.84x | N/A |
| 2024 | $119.63 Million | $4.12 Million | -$12.79 Million | 29.07x | N/A |
Competitor Companies of ALCJ by Market Capitalization
Companies near Crossject in the global market cap rankings as of March 18, 2026.
Key companies related to Crossject by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Crossject Historical Marketcap From 2015 to 2026
Between 2015 and today, Crossject's market cap moved from $527.48 Million to $ 112.62 Million, with a yearly change of -5.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €112.62 Million | -4.57% |
| 2025 | €118.01 Million | -1.35% |
| 2024 | €119.63 Million | -54.94% |
| 2023 | €265.47 Million | +50.83% |
| 2022 | €176.01 Million | +16.28% |
| 2021 | €151.36 Million | -7.01% |
| 2020 | €162.78 Million | +33.26% |
| 2019 | €122.15 Million | +90.72% |
| 2018 | €64.05 Million | -73.10% |
| 2017 | €238.12 Million | +3.28% |
| 2016 | €230.55 Million | -56.29% |
| 2015 | €527.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Crossject was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $112.62 Million USD |
| MoneyControl | $112.62 Million USD |
| MarketWatch | $112.62 Million USD |
| marketcap.company | $112.62 Million USD |
| Reuters | $112.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.